Henoch Schonlein purpura in pediatric patients with inflammatory bowel disease: A case series

Anjani P. Sheth*, Karina L. Vivar, Annette M. Wagner, Lacey L. Kruse

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Retrospective chart review was conducted to identify the clinical features of Henoch Schonlein purpura (HSP) in five children with inflammatory bowel disease (IBD). All five children, four of which were on anti-TNF therapies, experienced the onset of HSP after their IBD diagnosis. HSP averaged 20.8 months in duration. The patients in our cohort, particularly those on anti-TNF therapy for inflammatory bowel disease, experienced chronic and recurrent courses of HSP.

Original languageEnglish (US)
Pages (from-to)1389-1392
Number of pages4
JournalPediatric dermatology
Volume38
Issue number5
DOIs
StatePublished - Sep 1 2021

Keywords

  • Purpura
  • Schoenlein-Henoch
  • case reports
  • child
  • inflammatory bowel diseases
  • tumor necrosis factor-alpha

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Dermatology

Fingerprint

Dive into the research topics of 'Henoch Schonlein purpura in pediatric patients with inflammatory bowel disease: A case series'. Together they form a unique fingerprint.

Cite this